These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4177873)

  • 1. [Treatment of terminal cancer and relapsed cancer by 5-5-FU(5-fluorouracil)].
    Uemura T; Amba T; Hamada M; Tanaka S
    Gan No Rinsho; 1968 Jul; 14(7):553-6. PubMed ID: 4177873
    [No Abstract]   [Full Text] [Related]  

  • 2. Destruction of both extensive local recurrent and primary breast cancer with topical aqueous 5-FU: a clinical observation.
    Zweig JI; Kabakow B
    Cancer Treat Rep; 1986 Jul; 70(7):936-7. PubMed ID: 3719590
    [No Abstract]   [Full Text] [Related]  

  • 3. Palliative treatment of metastasized breast cancer with 5-FU in slow intravenous infusion.
    Huys J; Van Vaerenbergh PM
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):775-80. PubMed ID: 4189483
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
    Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A
    Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
    Tanino H; Oura S; Hoffman RM; Kubota T; Furukawa T; Arimoto J; Yoshimasu T; Hirai I; Bessho T; Suzuma T; Sakurai T; Naito Y
    Anticancer Res; 2001; 21(6A):4083-6. PubMed ID: 11911296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of ambulatory cancer chemotherapy for recurrent breast cancer].
    Takahashi N; Nitta A; Kunii Y; Ota K
    Gan To Kagaku Ryoho; 1994 Dec; 21 Suppl 4():439-43; discussion 443-4. PubMed ID: 7802447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
    Kim R; Osaki A; Toge T
    Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy with chlorambucil and 5-fluorouracil in primary breast cancer (Cooperative Study Heidelberg).
    Kaufmann M; Fournier DV; Sievers H; Staib I; Wöllgens P; Nedden R; Lochbühler H; Queisser W; Christmann D; Bühner R; Pfuhl PJ; Henningsen B; Kuttig H; Wysocki S; Thüre D; Köhler C; Drings P
    Eur J Cancer (1965); 1980; Suppl 1():157-60. PubMed ID: 7032925
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intra-arterial infusion chemotherapy for unresectable or recurrent breast cancer].
    An M; Matsumoto Y; Kishi T; Terakado H; Ikawa M; Hamada E; Watanabe Y; Nakasato S; Murata M; Takaki S; Miura T; Idezuki Y; Kobayashi M
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1330-2. PubMed ID: 9703820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of relapse after adjuvant treatment with combination chemotherapy or 5-fluorouracil alone in high-risk breast cancer. A Western Cancer Study Group Project.
    Chlebowski RT; Weiner JM; Luce J; Hestorff R; Lang JE; Reynolds R; Godfrey T; Ryden VM; Bateman JR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4399-403. PubMed ID: 7306966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM; Abeloff MD; Lenhard RE; Baker RR
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract]   [Full Text] [Related]  

  • 14. First-line chemotherapy with fluorouracil-epirubicin-navelbine (FEN) combination in advanced breast cancer.
    Ardavanis A; Tryfonopoulos D; Orphanos G; Ioannidis G; Karamouzis M; Rigatos G
    Anticancer Res; 2005; 25(6C):4493-8. PubMed ID: 16334132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ineffectiveness of sequential high dose methotrexate and 5-fluorouracil combined with epirubicin (FEMTX regimen) as a salvage therapy in advanced colorectal cancers and other gastrointestinal tumors.
    Adenis A; Leriche N; Pion JM; Vanlemmens L; Bonneterre J
    Anticancer Res; 1996; 16(4A):2063-7. PubMed ID: 8712743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant and palliative treatment of colorectal cancer with fluorinated pyrimidines. A pharmacological and clinical review.
    Gustavsson B; Hafström L
    Acta Chir Scand Suppl; 1981; 504():1-28. PubMed ID: 6176091
    [No Abstract]   [Full Text] [Related]  

  • 17. The effectiveness of 5-fluorouracil administered orally.
    Ansell BF
    Va Med Mon (1918); 1975 May; 102(5):370-4. PubMed ID: 1154845
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comments on the treatment of solid tumors with 5-fluorouracil].
    Alberto P
    Ther Umsch; 1969 Jul; 26(7):415-21. PubMed ID: 4308282
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
    Chu L; Sutton LM; Peterson BL; Havlin KA; Winer EP
    J Infus Chemother; 1996; 6(4):211-6. PubMed ID: 9229318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Marcrae KD
    Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.